Abstract
Background: This study was done to evaluate the results of the combined use of chemo- and radiotherapy before surgery in a group of patients with squamous cell esophageal carcinoma after a median follow-up period of more than 5 years.
Methods: Between June 1987 and January 1995, 111 patients with squamous cell carcinoma of the thoracic esophagus were submitted to a preoperative course of radiotherapy (3000 cGy) and chemotherapy (cisplatin and 5-FU) before surgery in the First Division of General Surgery at the University of Verona.
Results: The neoadjuvant treatment was completed in 90.9% of the cases (101/111). After an average of 29 days, 87 patients underwent surgery (operability rate: 78.3%) and, of these, 80 underwent esophagectomy (resectability rate: 91.9%). Histopathologic studies showed no residual disease in the specimen (T0) in 17 cases (21.2%), only microscopic clusters of neoplastic cells within the esophageal wall (Minimal Residual Disease, MRD) in 14 cases (17.5%) and in 5 cases the tumor did not extend beyond the submucosal layer (T1). The median overall survival time of the 111 patients who were eligible for the study protocol was 14 months, and the 2- and 5-year survival rates were 32.0% and 17.5%, respectively. Kaplan-Meier determination of survival showed a statistically significant difference between the good responders (T0, T1, and MRD) to the neoadjuvant treatment and the remaining cases. The 2- and 5-year survival rates were 50.3% and 34.9%, respectively, in the good responder group compared with 26.7% and 10.7%, respectively, in the other cases, with a median survival time of 24 months vs. 13 months, respectively.
Conclusions: The neoadjuvant treatment showed promising results, especially in the group of patients that had a good response. The identification of these patients may be the key to selecting which patients should be submitted to preoperative radio- and chemotherapy.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
REFERENCES
Popp MB, Hawley D, Reiseng J. Improved survival in squamous oesophageal cancer. Arch Surg 1986;121:1330–1335.
Austin JC, Postier RG, Elkins RC. Treatment of oesophageal cancer: the continued need for surgical resection. Am J Surg 1986;152:592–596.
Wolfe WG, Burton GV, Seigler HF, Croker IR, Vaughn A. Early result with combined modality therapy for carcinoma of the oesophagus. Ann Surg 1987;205:563–571.
Forastiere AA, Orringer MB, Perez-Tamayo C, Urba SG, Zahurak M. Preoperative chemoradiation followed by transhiatal esophagectomy for carcinoma of the oesophagus: final report. J Clin Onc 1993;11:1118–1123.
Stahl M, Wilke H, Fink U, Stuschke M, et al. Combined preoperative chemotherapy and radiotherapy in patients with locally advanced oesophageal cancer: interim analysis of a phase II trial. J Clin Oncol 1996;14:829–837.
Roth JA, Pass HI, Flanagan MM, Graeber GM, Rosemberg JC, Steinberg S. Randomised clinical trial of preoperative and postoperative adjuvant chemotherapy with cisplatin, vindesine, and bleomycin for carcinoma of the oesophagus. J Thor Cardiovasc Surg 1988;96:242–248.
Tubiana M. The role of local treatment in the cure of cancer. Eur J Cancer 1992;28A:2061–2069.
Swisher SG, Holmes CE, Kelly KH, Doty JE, Zinner MJ, McFadden DW. The role of neoadjuvant therapy in surgical resectable oesophageal cancer. Arch Surg 1996;131:819–825.
Ide H, Nakamura T, Hayashi K. Neoadjuvant chemotherapy with cisplatinum/5-Fluorouracil/low-dose leucovirin for advanced squamous cell carcinoma of the oesophagus. Semin Surg Oncol 1997;13:263–269.
Laterza E, Griso C, Urso SU, de Manzoni G, Malagò Massimo, Oliani C, Cordiano C. Induction therapy for squamous carcinoma of the thoracic oesophagus. Ann thorac Surg 1994;57:1126–1132.
Hermanck P, Sobin LH, eds. Union Internationale Contre le Cancer. TNM classification of malignant tumors; 4th ed. Geneva: Springer-Verlag, 1987.
Podolski WJ, Xavier AM, Wittlinger PS, Padmanabhan A. Radiotherapy alone and chemoradiation for nonmetastatic oesophageal carcinoma. Cancer 1989;63:2397–2403.
Kaplan EL, Meier P. Nonparametric estimation from incomplete observation. J Am Stat Assoc 1958;53:457–481.
Kelsen DP, Ilson DH. Chemotherapy and combined-modality therapy for oesophageal cancer. Chest 1995;107:224S–232S.
Vokes EE, Weichselbaum RR. Concomitant chemoradio-therapy: rationale and clinical experience in patients with solid tumours. J Clin Oncol 1990;8:911–934.
Naunheim KS, Petruska PJ, Roy TS, Andrus CH, Johnson FE, Schlueter JM, Baue AE. Preoperative chemotherapy and radiotherapy for oesophageal carcinoma. J Thorac Cardiovasc Surg 1992;103:887–885.
Bedenne L, Milan C, Brriè F, Seitz JF, Renard P, Conroy T, Herr JP. Preoperative radiotherapy and chemotherapy in epidermoid oesophageal cancers. Result of a phase II multicentric trial by the French Foundation for Carcinology of the Digestive Tract (FFDC). Proc Am Soc Clin Oncol Proc 1993;199:(Abstr 587).
Malhaire JP, Labat JP, Lozac’h P, Simon H, Lucas B, Topart P, Volant A. Preoperative concomitant radiochemotherapy in squamous cell carcinoma of the oesophagus: result of a study of 56 patients. Int J Rad Oncol Biol Phys 1996;34:429–437.
Kavanagh B, Anscher M, Leopold K, et al. Patterns of failure following combined modality therapy for oesophageal cancer. Int J Rad Oncol Biol Phys 1992;24:633–636.
Laterza E, de Manzoni G, Veraldi GF, Guglielmi A, and Cordiano C. Manual versus mechanical cervical esophago-gastric anastomosis: a randomised trial. Eur J Surg 1999 (in press).
Van Raemdonck D, Van Cutsem E, Menten J, Ectors N, Coosemans W, De Leyn P, Lerut T. Induction therapy for clinical T4 oesophageal carcinoma, a plea for continued surgical exploration. Eur J Car Thor Surg 1997;11:828–1837.
Mandard AM, Dalibard F, Mandard JC, et al. Pathologic assessment of tumour regression after preoperative chemoradiotherapy of oesophageal carcinoma: clinicopatologic correlation. Cancer 1994;73:2680–2686.
Lam KY, Law S, Ma LT. Pre-operative chemotherapy for squamous cell carcinoma of the oesophagus: do histological assessment and p53 over-expression predict chemo-responsiveness? Eur J Can 1997;33(8):1221–1225.
Wu GS, El-Deiry WS. Apoptic death of tumours cell correlates with chemosensitivity, independent of p53 or Bcl-2. Clin Can Res 1996;2:623–623.
Laterza E, de Manzoni G, Guglielmi A, Rodella L, Tedesco P, Cordiano C. Endoscopic ultrasonography in the staging of oesophageal carcinoma after preoperative and radio- chemotherapy. Ann Thorac Surg 1999;67:1466–1469.
Rosch T, Classen M. Oesophageal carcinoma, in gastroenterologic endosonography. Stuttgart: Georg Thieme Verlag, 1992;45–62.
Walsh TN, Noonan N, Hollywood D, Kelly A, Keeling N, Hennessy TPJ. A comparison of multimodal therapy and surgery for oesophageal adenocarcinoma. N Engl J Med 1996;15:462–467.
Urba SG, Orringer MB, Perez-Tamayo C. Concurrent preoperative chemotherapy and radiation therapy in localised oesophageal adenocarcinoma. Cancer 1992;69:285–291.
Apinop C, Puttisack P, Preecha N. A prospective study of combined therapy in oesophageal cancer. Hepato-gastroenterol. 1994;41:391–393.
Le Prise E, Etienne PL, Meunier B, et al. A randomised study of chemotherapy, radiation therapy, and surgery versus surgery for localised squamous cell carcinoma of the oesophagus. Cancer 1994;73:1779–1784.
Walsh TN, Noonan N, Hollywood D, Kelly A, Keeling N, Hennessy TPJ. Multimodality Treatment Plus Surgery Versus Surgery Alone for Oesophageal Squamous Cell Carcinoma. In Peracchia A., eds. Recent Advances in Disease of the Oesophagus. Monduzzi 1995:451–456.
Bosset J-F, Gignoux M, Triboulet J-P, et al. Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the oesophagus. NEJM 1997;337:161–167.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Laterza, E., de’ Manzoni, G., Tedesco, P. et al. Induction Chemo-Radiotherapy for Squamous Cell Carcinoma of the Thoracic Esophagus: Long-Term Results of a Phase II Study. Ann Surg Oncol 6, 777–784 (1999). https://doi.org/10.1007/s10434-999-0777-x
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s10434-999-0777-x